Shonda A. Foster - Concepedia

Author

Shonda A. Foster

Eli Lilly (United States)

Also Known As

S A Foster, S Foster, S. A. Foster, S. Foster, S.A. Foster, Shonda A Foster, Shonda A. Foster, Shonda Foster, T Gentry

Publications

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Thomson Reuters (United States)Truven Health Analytics (United States)Lupus Foundation of America Eli Lilly (United Kingdom)

About

Shonda A. Foster is an author at Eli Lilly (United States) specializing in medicine, public health, and orthopaedics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	146
2	Public Health	4	4	157
3	Health Behavior	2	2	83
4	Health Policy	2	2	74
5	Health Promotion	1	1	27

Shonda A. Foster

Publications

873

Citations

H-Index

Page 1

	Year	Citations
Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus—the Hopkins Lupus Cohort S. Al Sawah, Xiang Zhang, Baojin Zhu, Lupus Science & Medicine	2015	209
The impact of teriparatide adherence and persistence on fracture outcomes Shan‐Fu Yu, Russel Burge, Shonda A. Foster, Osteoporosis International Skeletal TraumaBone HealthFracture OutcomesFracture HealingSurgery	2011	57
Development of the Smoking Cessation quality of life questionnaire Abayomi O. Olufade, James W. Shaw, Shonda A. Foster, Clinical Therapeutics Tobacco CessationQuality Of LifeTobacco ControlSmoking Cessation QualityLife Assessment	1999	56
Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis S. Al Sawah, Shonda A. Foster, Orin M. Goldblum, Journal of Medical Economics	2017	42
Adherence and persistence with teriparatide among patients with commercial, Medicare, and Medicaid insurance Shonda A. Foster, Kathleen A. Foley, Eric S. Meadows, Osteoporosis International Preventive MedicineMedicaid InsuranceHealth PolicyTreatment And PreventionPatient Support	2010	41
Cycling Through Migraine Preventive Treatments: Implications for All-Cause Total Direct Costs and Disease-Specific Costs Janet H. Ford, Krista Schroeder, Allen W. Nyhuis, Journal of Managed Care & Specialty Pharmacy	2018	41
Assessment of the Clinical Management of Fragility Fractures and Implications for the New HEDIS Osteoporosis Measure Kathleen A. Foley, Shonda A. Foster, Eric S. Meadows, Medical Care Bone DiseaseClinical ManagementSkeletal TraumaPrimary CareBone Health	2007	33
Real-world health outcomes in adults with moderate-to-severe psoriasis in the United States: a population study using electronic health records to examine patient-perceived treatment effectiveness, medication use, and healthcare resource utilization April W. Armstrong, Shonda A. Foster, Brian S. Comer, BMC Dermatology	2018	31
Cost per additional responder for ixekizumab and other FDA-approved biologics in moderate-to-severe plaque psoriasis S. Al Sawah, Shonda A. Foster, Russel Burge, Journal of Medical Economics	2017	28
Direct and Indirect Costs Among United States Commercially Insured Employees With Migraine Adrienne M. Gilligan, Shonda A. Foster, Amy Sainski‐Nguyen, Journal of Occupational and Environmental Medicine	2018	28

Page 1